Sernova Secures Commercial Rights to Proprietary Stem Cell Derived TechnologiesMarketWatch"This agreement provides us with a proprietary source of stem cell derived glucose responsive therapeutic cells. When placed within Sernova's prevascularized Cell Pouch(TM), and protected locally from immune system attack, we believe that Sernova has
http://blog.zandcell.com/sernova-secures-commercial-rights-to-proprietary-stem-cell-derived-technologies-marketwatch/
Inga kommentarer:
Skicka en kommentar